breast cancerprognosistargeted therapyTo the Editors: On the basis of human epidermal growth factor receptor 2 ( HER-2 ) status, patients with breast cancer are classified as having HER-2 -negative or HER-2 -positive disease. Prognosis of HER-2 -positive, as compared to HER-2 -negative, ...
chemotherapy and radiation are the most important treatments for Her-2 negative breast cancer due to poor targeted therapy.Neoadjuvant chemotherapy has many advantages, for example, it can reduce tumor stage,to achieve surgical operation,maintain breast and armpit, and provide sensitive...
HER-2/neu in node-negative breast cancer: Prognostic significance of overexpression influenced by the presence of in situ carcinoma HER-2/neu in node-negative breast cancer: Prognostic significance of overexpression influenced by the presence of in situ carcinoma......
In Part B, a lower single dose of HER3-DXd (5.6 mg/kg) was evaluated in 20 patients with untreated early-stage HR+/HER2- breast cancer and 17 patients with triple-negative breast cancer (TNBC)8. The primary endpoint of SOLTI-1805 TOT-HER3 of the trial was to evaluate changes in ...
2023年8月, Frontiers in Oncology杂志发表了一项研究,题为《HER-2 ultra-low breast cancer: exploring the clinicopathological features and prognosis in a retrospective study》,为我们提供了关于HER-2超低表达乳腺癌的深入分析。 研...
ObjectiveTo investigate the expression of HER-2 protein and gene amplification in malignant melanoma and evaluation of HER-2 in malignant melanoma occurrence, development and prognosis.MethodsUsing PV-9000 two steps method and in situ chemical hybridization to detect the expression of HER-2 protein, ...
(Hatada, Takuya)3;Miyoshi, Y (Miyoshi, Yasuo)1.High Ki-67 expression and low progesterone receptor expression could independently lead to a worse prognosis for postmenopausal patients with estrogen receptor-positive and HER2-negative breast cancer[J].Clinical Breast Cancer.2015,Vol.15(No.3):204...
2023年8月, Frontiers in Oncology杂志发表了一项研究,题为《HER-2 ultra-low breast cancer: exploring the clinicopathological features and prognosis in a retrospective study》,为我们提供了关于HER-2超低表达乳腺癌的深入分析。 研究方法: 本研究是一项回顾性队列研究,旨在探索HER-2超低表达乳腺癌患者的临床病...
展开更多 Background and Aims:In clinical practice,both HER-2 low expression and HER-2 zero expression breast cancers are categorized as HER-2 negative breast cancer,and are considered ineligible for HER-2 targeted therapy.However,recent clinical trial results of new anti-HER-2 a...MORE 作者...
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers Introduction Lymphocyte infiltration (LI) is often seen in breast cancer but its importance remains controversial. A positive correlation of human epiderma... A Rody,U Holtrich,L Pusztai,....